MedPath

Influenza A virus A/Michigan/45/2015 X-275 (H1N1) antigen (formaldehyde inactivated)

Generic Name
Influenza A virus A/Michigan/45/2015 X-275 (H1N1) antigen (formaldehyde inactivated)
Brand Names
Fluzone High-dose, Fluzone Quadrivalent
Drug Type
Biotech
Chemical Formula
-
CAS Number
-
Unique Ingredient Identifier
8KSK0802BP
Background

A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". This defence includes the production of humoral immunity through the development of antibodies (through memory B cells) and of cell-mediated immunity through the production of T-lymphocytes. Upon re-exposure to infectious influenza virus, the immune system is prepared to identify and destroy the virus as there are circulating antibodies that recognize that particular component of the virus that it was previously exposed to.

There are two basic types of vaccines available: inactivated influenza vaccine (IIV) and live attenuated influenza vaccine (LAIV). Inactivated vaccines contain a virus particle that has been grown in media and then subsequently killed, or inactivated, through exposure to heat or chemicals such as formaldehyde 3. Inactivated virus cannot replicate, and therefore cannot cause disease from infection, even in immunocompromised individuals. In contrast, live vaccines are produced from "wild-type" or disease-causing viruses that have been attenuated, or weakened, through various laboratory techniques. Live vaccines maintain their replicative ability.

Associated Conditions
-
Associated Therapies
-
pharmacytimes.com
·

NCPA 2024: Latest Updates on Respiratory Vaccines

Pharmacists must stay updated on vaccine recommendations as COVID-19, influenza, RSV, and other viruses circulate. COVID-19 vaccines for 2024-2025 include mRNA from Moderna, Pfizer, and Novavax. ACIP recommends 1 dose for those 5 years and older, with additional doses for high-risk groups. Influenza vaccines have a new trivalent formulation, and RSV vaccination is crucial for older adults. Pneumococcal vaccination age has been lowered to 50, with new vaccines targeting prevalent serotypes.
© Copyright 2025. All Rights Reserved by MedPath